On air · 2 of 3 networks
Fujirebio
- fujirebio.com
- Healthcare & Life Sciences
- JP
- 716 employees
Fujirebio’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 48. Watch Fujirebio with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 11 | Checked 28 Oct 2026 | See all 48 ads → | ||
| Meta | Not checked | — | |||
| Running | 72 | Ads on the Google Ads Transparency Center | Checked 30 Oct 2026 | Collect them with the API → |
Fujirebio has 11 live LinkedIn ads. We recorded 72 Google ads on 30 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 6 Oct 2026
What a great turnout for our third edition of the #NeuroBiomarkerTalks! 🙌 It was an insightful session, and the Q&A brought valuable perspectives that enriched the discussion. A sincere thank‑you to our speakers, Dr. Daniel Alcolea and Prof. Dr. Jonathan Schott, for sharing their expertise and contributing to a highly engaging webinar. Missed it? You can watch the full recording here 🎥 https://lnkd.in/evbmMtGg Feel free to reach out to our team at the Fujirebio Neuro Center of Excellence, we’re here to support your next steps. Explore our full portfolio here: https://lnkd.in/eUUeEnXA Looking forward to staying connected! 🤝
- LINKEDIN · IMAGESince 6 Oct 2026
What a great turnout for our third edition of the #NeuroBiomarkerTalks! 🙌 It was an insightful session, and the Q&A brought valuable perspectives that enriched the discussion. A sincere thank‑you to our speakers, Dr. Daniel Alcolea and Prof. Dr. Jonathan Schott, for sharing their expertise and contributing to a highly engaging webinar. Missed it? You can watch the full recording here 🎥 https://lnkd.in/evbmMtGg Feel free to reach out to our team at the Fujirebio Neuro Center of Excellence, we’re here to support your next steps. Explore our full portfolio here: https://lnkd.in/dVFGAQqK Looking forward to staying connected! 🤝
- LINKEDIN · IMAGESince 24 Sept 2026
📅 Reserve your seat for our live webinar: September 30th at 17:00 CET. We are pleased to invite you to the third session of our webinar series “Neuro Biomarker Talks: From Discovery to Diagnostic Impact”, a series that will highlight emerging biomarkers and their potential to advance the neuro field. In this webinar, titled: “ALZHEIMER’S DISEASE DIAGNOSIS IN MOTION: Bringing Plasma pTau 217 from Validation to Clinical Practice", Dr. Daniel Alcolea and Prof. Dr. Jonathan Schott will explore how plasma pTau 217 is helping to optimize the Alzheimer's disease diagnostic pathway through more accessible and timely diagnosis. The webinar will be broadcasted live on Wednesday September 30th from 17:00 to 18:00 CET. 🎟️ Reserve your seat now: https://lnkd.in/exHQtR4K
- LINKEDIN · IMAGESince 18 Sept 2026
Join us for the third edition of our webinar series: Neuro Biomarker Talks! We are pleased to invite you to the third session of our webinar series “Neuro Biomarker Talks: From Discovery to Diagnostic Impact”, a series that will highlight emerging biomarkers and their potential to advance the neuro field. In this webinar, titled: “ALZHEIMER’S DISEASE DIAGNOSIS IN MOTION: Bringing Plasma pTau 217 from Validation to Clinical Practice", Dr. Daniel Alcolea and Prof. Dr. Jonathan Schott will explore how plasma pTau 217 is helping to optimize the Alzheimer's disease diagnostic pathway through more accessible and timely diagnosis. The webinar will be broadcasted live on Wednesday September 30th from 17:00 to 18:00 CET.
- LINKEDIN · CAROUSELSince 18 Sept 2026
Join us for the third edition of our webinar series: Neuro Biomarker Talks! In this session, Dr. Daniel Alcolea and Prof. Dr. Jonathan Schott will discuss how plasma pTau 217 is helping to optimize the Alzheimer's disease diagnostic pathway through more accessible and timely diagnosis. The webinar will be broadcasted live on Wednesday September 30th from 17:00 to 18:00 CET.
- LINKEDIN · IMAGESince 18 Sept 2026
📅 Reserve your seat for our live webinar: September 30th at 17:00 CET. We are pleased to invite you to the third session of our webinar series “Neuro Biomarker Talks: From Discovery to Diagnostic Impact”, a series that will highlight emerging biomarkers and their potential to advance the neuro field. In this webinar, titled: “ALZHEIMER’S DISEASE DIAGNOSIS IN MOTION: Bringing Plasma pTau 217 from Validation to Clinical Practice", Dr. Daniel Alcolea and Prof. Dr. Jonathan Schott will explore how plasma pTau 217 is helping to optimize the Alzheimer's disease diagnostic pathway through more accessible and timely diagnosis. The webinar will be broadcasted live on Wednesday September 30th from 17:00 to 18:00 CET.
6 of 48 adsSign up to see every Fujirebio ad, filter by format and date, and get alerts on new ones.
See all 48 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.